Arecor Therapeutics (AREC) Competitors

Arecor Therapeutics (LON:AREC) and Ondine Biomedical (LON:OBI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

Do institutionals & insiders believe in AREC or OBI?

44.1% of Arecor Therapeutics shares are held by institutional investors. Comparatively, 20.6% of Ondine Biomedical shares are held by institutional investors. 25.3% of Arecor Therapeutics shares are held by insiders. Comparatively, 36.7% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is AREC or OBI more profitable?

Arecor Therapeutics has a net margin of -176.89% compared to Ondine Biomedical's net margin of -873.84%. Arecor Therapeutics' return on equity of -118.67% beat Ondine Biomedical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arecor Therapeutics	-176.89%	-118.67%	-37.31%
Ondine Biomedical	-873.84%	-684.01%	-159.71%

Which has more volatility and risk, AREC or OBI?

Arecor Therapeutics has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Ondine Biomedical has a beta of 0.1, indicating that its share price is 90% less volatile than the S&P 500.

Which has preferable valuation and earnings, AREC or OBI?

Ondine Biomedical has lower revenue, but higher earnings than Arecor Therapeutics. Ondine Biomedical is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arecor Therapeutics	£6.04M	3.95	-£10.68M	-£28.30	-2.23
Ondine Biomedical	C$48.60K	2,383.69	-C$424.66K	-C$3.32	-4.85

Does the media favor AREC or OBI?

In the previous week, Ondine Biomedical had 4 more articles in the media than Arecor Therapeutics. MarketBeat recorded 4 mentions for Ondine Biomedical and 0 mentions for Arecor Therapeutics. Ondine Biomedical's average media sentiment score of 0.09 beat Arecor Therapeutics' score of 0.00 indicating that Ondine Biomedical is being referred to more favorably in the news media.

Company	Overall Sentiment
Arecor Therapeutics	Neutral
Ondine Biomedical	Neutral

Summary

Ondine Biomedical beats Arecor Therapeutics on 7 of the 13 factors compared between the two stocks.